Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence.

• Type of Material: Article
• Authors: Clifford J Bailey, Aston University; James Gavin III, Emory University
• Language: English
• Date: 2021-01
• Publisher: Copyright American Diabetes Association
• Publication Version: Final Published Version
• Copyright Statement: © 2020 by the American Diabetes Association
• Final Published Version (URL): http://dx.doi.org/10.2337/cd20-0076
• Title of Journal or Parent Work: Clinical Diabetes
• Volume: 39
• Issue: 1
• Start Page: 64
• End Page: 71
• Grant/Funding Information: Funding for the development of this manuscript was provided by Abbott Diabetes Care.
• Keywords: Glucose Monitoring; glycemic
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

Optimizing glycemic control remains a shared challenge for clinicians and their patients with diabetes. Flash continuous glucose monitoring (CGM) provides immediate information about an individual's current and projected glucose level, allowing users to respond promptly to mitigate or prevent pending hypoglycemia or hyperglycemia. Large randomized controlled trials (RCTs) have demonstrated the glycemic benefits of flash CGM use in both type 1 and type 2 diabetes. However, whereas RCTs are mostly focused on the efficacy of this technology in defined circumstances, real-world studies can assess its effectiveness in wider clinical settings. This review assesses the most recent real-world studies demonstrating the effectiveness of flash CGM use to improve clinical outcomes and health care resource utilization in populations with diabetes.